Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents

Aneeta Patel, Sissy Jhiang, Shalini Dogra, Richard Terrell, Patricia A. Powers, Cydney Fenton, Catherine A. Dinauer, R. Michael Tuttle, Gary L. Francis

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Abstract

The sodium-iodide symporter (NIS) is expressed by papillary (PTC) and follicular (FTC) thyroid carcinoma, and is essential for iodine uptake. We hypothesized that PTC and FTC with detectable NIS immunostaining would be more amenable to radioactive iodine (13I) treatment and follow a more benevolent course. To test this, we determined NIS expression by immunohistochemistry in 23 PTC, 9 FTC, and 12 benign thyroid lesions from children and adolescents. NIS expression was determined by two blinded examiners and graded as absent = 0, minimal = 1, moderate = 2, intense = 3, and very intense = 4. NIS was detected in 35% (eight of 23) of PTC, 44% (four of 9) of FTC, 25% (two of eight) of benign tumors, and 100% (four of four) of autoimmune lesions. The intensity of NIS expression was similar in PTC (0.61 ± 0.24), FTC (0.56 ± 0.24), and benign tumors (0.50 ± 0.33) but was more intense in autoimmune lesions (3.0 ± 0.7, p < 0.005). Distant metastases were found only among PTC with undetectable NIS (two of 15, 13%), and recurrence developed exclusively from PTC and FTC with undetectable NIS (four of 20, 20% versus zero of 12, p = 0.043). The dose of iodine 131 required to achieve remission in the five patients with PTC who had undetectable NIS (213.3 ± 53 mCi) was greater than that required by patients with similar age and extent of disease for whom NIS expression is unknown (109 ± 22 mCi, p = 0.06). We conclude that NIS expression is associated with a lower risk of recurrence for PTC and FTC of children and adolescents.

Original languageEnglish (US)
Pages (from-to)737-744
Number of pages8
JournalPediatric Research
Volume52
Issue number5
DOIs
StatePublished - Nov 1 2002
Externally publishedYes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents'. Together they form a unique fingerprint.

Cite this